Zobrazeno 1 - 10
of 108
pro vyhledávání: '"sobrerol"'
Autor:
Varricchio A, Ciprandi G
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 5471-5477 (2024)
Attilio Varricchio,1 Giorgio Ciprandi,2 Study Group on respiratory infection management in clinical practice included:Francesco Paolo Brunese, Luigi Costanzo, Lorenzo Cresta, Maurizio Daccò, Donatella Del Gaizo, Carla Dominici, Cosimo Lanza, Michele
Externí odkaz:
https://doaj.org/article/7dfed8a5ac6c40c3bab546a86d029e83
Autor:
Giorgio Ciprandi, Attilio Varriccchio
Publikováno v:
Children, Vol 10, Iss 7, p 1210 (2023)
Respiratory tract infections (RTIs) are usually characterized by mucus hypersecretion. This condition may worsen and prolong symptoms and signs. For this reason, reducing mucus production and improving mucus removal represent relevant aspects of mana
Externí odkaz:
https://doaj.org/article/6dd6590f83da431cb3ea0405219c4cef
Publikováno v:
Nanomaterials, Vol 13, Iss 9, p 1554 (2023)
It is presented that the activated carbon was carboxylated with hydrogen peroxide and then acylated with 2-methylimidazole to prepare the porous carbon support with a surface imidazolated modification. Through the adsorption of phosphotungstic acid o
Externí odkaz:
https://doaj.org/article/739e9c3d4f634fdca36412b6a7b2cddb
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 167 (2022)
Sobrerol, an oral mucolytic agent, in a recent study showed promise for treating multiple sclerosis. A human equivalent dose of 486 mg of sobrerol administered thrice daily (i.e., 1459 mg of daily dose) demonstrated the highest therapeutic efficacy f
Externí odkaz:
https://doaj.org/article/f18d1223716e4d529cabe8486ef7c4c4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pharmaceutics
Pharmaceutics; Volume 14; Issue 1; Pages: 167
Pharmaceutics, Vol 14, Iss 167, p 167 (2022)
Pharmaceutics; Volume 14; Issue 1; Pages: 167
Pharmaceutics, Vol 14, Iss 167, p 167 (2022)
Sobrerol, an oral mucolytic agent, in a recent study showed promise for treating multiple sclerosis. A human equivalent dose of 486 mg of sobrerol administered thrice daily (i.e., 1459 mg of daily dose) demonstrated the highest therapeutic efficacy f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a35dcdfb3a8e98379442e644b3e6b9
https://pubmed.ncbi.nlm.nih.gov/35057064
https://pubmed.ncbi.nlm.nih.gov/35057064
Autor:
Stamm, Arne
Rising environmental awareness and responsibility has increased the demand for novel, bio-based sustainable materials. Therefore, there is an extensive need to research and develop closed-loop materials from novel feedstocks that can be generated usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d5ec6485f9b33ac38559074938fc11a0
http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-294245
http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-294245
Autor:
Björn Schmidt, Eva Malmström, Arne Stamm, Joakim Engström, Linda Fogelström, Per-Olof Syrén, Mattias Tengdelius
Publikováno v:
Green Chemistry. 21:2720-2731
Sobrerol methacrylate (SobMA) was synthesized and subsequently polymerized using different chemical and enzymatic routes. Sobrerol was enzymatically converted from -pinene in a small model scale by ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d7e59ac95ffcf689ed97de90a70939
https://doi.org/10.1039/c9gc00718k
https://doi.org/10.1039/c9gc00718k
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Green Chemistry. 20:4880-4890
Sobrerol acrylate (SobAcr) and sobrerol methacrylate (SobMet) were synthesized for the first time through the functionalization of sobrerol with double bonds. Sobrerol was obtained by a green route that involved the hydration of α-pinene oxide in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9c9efa60600091c28e174cc9ab4532a
https://doi.org/10.1039/c8gc01214h
https://doi.org/10.1039/c8gc01214h